Reported 9 months ago
SoftBank Group has launched a joint venture with Tempus AI to analyze personal medical data using artificial intelligence (AI) for treatment recommendations. The collaboration follows SoftBank's $200 million investment in Tempus in April, with plans to expand the AI-informed healthcare services provided by Tempus from the U.S. to Japan. The venture, expected to close in July, aims to revolutionize healthcare in Japan through innovative AI technology and genomic testing services.
Source: YAHOO